Determinants of white-coat syndrome assessed by ambulatory blood pressure or self-measured home blood pressure

Blood Pressure Monitoring

Volumn 8, Issue 1, 2003, Pages 37-40

  Den Hond, Elly ^a,d   Celis, Hilde ^a   Vandenhoven, Guy ^b   O'Brien, Eoin ^c   Staessen, Jan A ^a  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^b ASTRAZENECA   (United Kingdom)

^c BEAUMONT HOSPITAL   (Ireland)

^d Hypertensie Cardiovasculaire R   (Belgium)

Author keywords

Ambulatory blood pressure; Self measured home blood pressure; White coat effect; White coat hypertension

Indexed keywords

ADULT; AGE; AGED; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BODY MASS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; SELF EVALUATION; SMOKING; WHITE COAT HYPERTENSION;

AGE FACTORS; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BODY MASS INDEX; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHYSICIANS' OFFICES; SELF CARE; SEX FACTORS; SMOKING;

EID: 0037300145     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-200302000-00008     Document Type: Conference Paper

References (10)

1. Staessen JA, Celis H, Den Hond E, Giot C, Leeman M, O'Brien E, et al. Comparison of conventional and automated blood pressure measurements: interim analysis of the THOP trial. Blood Press Monit 2002; 7:61-62.
2. Celis H, Staessen JA, Buntinx F, Fagard R, Leeman M, Thijs L, Van Hedent T. Antihypertensive treatment based on home or office blood pressure measurement: protocol of the randomized controlled THOP trial. Blood Press Monit 1998; 3 (Suppl 1):S29-S35.
3. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705 CP, Philips HP5332 and Nissei DS-175. Blood Press Monit 1996; 1:55-62.
4. The Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure. The Sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
5. Chrysant SG. Treatment of white coat hypertension. Curr Hypertens Rep 2000; 2:412-417.
6. Gualdiero P, Niebauer J, Addison C, Clark SJ, Coats AJ. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring. Blood Press Monit 2000; 5:53-57.
7. Verdecchia P, Palatini P, Schillaci G, Mormino P, Porcellati C, Pessina AC. Independent predictors of isolated clinic ('white-coat') hypertension. J Hypertens 2001; 19:1015-1020.
8. Mikkelsen KL, Wiinberg N, Hoegholm A, Christensen HR, Bang LE, Nielsen PE, et al. Smoking related to 24-h ambulatory blood pressure and heart rate: a study in 352 normotensive Danish subjects. Am J Hypertens 1997; 10:483-491.
9. Mansoor CA, McCabe EJ, White WB. Determinants of the white-coat effect in hypertensive subjects. J Hum Hypertens 1996; 10:87-92.
10. Sandvik E, Steine S. White coat hypertension in a general practice. Prevalence, cardiovascular risk factors, and clinical implications. Scand J Prim Health Care 1998; 16:222-226.